Walleye Capital LLC Unity Biotechnology, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.56 - $1.29 $18,410 - $42,408	-32,875 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $15,472 - $39,971	-21,490 Reduced 39.53%	32,875 $37,000
Q4 2021 Mar 03, 2022	BUY	$1.3 - $3.17 $54,285 - $132,372	41,758 Added 331.23%	54,365 $79,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.5 $96,722 - $149,571	-33,238 Reduced 72.5%	12,607 $38,000
Q2 2021 Aug 16, 2021	BUY	$4.15 - $6.3 $190,256 - $288,823	45,845 New	45,845 $213,000
Q4 2020 Feb 16, 2021	SELL	$3.42 - $6.36 $157,644 - $293,164	-46,095 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $135,519 - $572,960	46,095 New	46,095 $159,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $85,220 - $129,534	-17,044 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $102,093 - $142,828	17,044 New	17,044 $123,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $18.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.